Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2018
Home
2018
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Convening 5th Midkine Symposium in Munich
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Investor Presentation
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 4C – Quarterly
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Secures Bloomingdales USA Partnership for evolis
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid to Commence Selling evolis into Chinese Market
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Address
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
5th Midkine Symposium Reinforces Clinical Potential for Cellmid’s Biotechnology Assets
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Investor Presentation July 2018
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Updates on Distribution of evolis
Prev page
1
2
3
4
5
6
7
8
Next page
